Association between endothelin-1 and collagen deposition in db/db diabetic mouse kidneys

Biochemical and Biophysical Research Communications

Volumn 339, Issue 1, 2006, Pages 65-70

  Mishra, Rangnath ^a   Emancipator, Steven N ^a   Kern, Timothy S ^a   Simonson, Michael S ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

Diabetes; Diabetic nephropathy; Endothelin 1; Fibrosis; Kidney

Indexed keywords

COLLAGEN; ENDOTHELIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; FIBROGENESIS; GLOMERULOPATHY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; KIDNEY; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; COLLAGEN; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; ENDOTHELIN-1; KIDNEY; KIDNEY GLOMERULUS; KIDNEY TUBULES; MALE; MICE;

ANIMALIA;

EID: 28144459475     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.10.180     Document Type: Article

References (42)

1. K. Takahashi, M.A. Ghatei, H.-C. Lam, D.J. O'Halloran, and S.R. Bloom Elevated plasma endothelin in patients with diabetes mellitus Diabetologia 33 1990 306 310
2. G. Ak, S. Buyukberber, A. Sevinc, H.M. Turk, M. Ates, R. Sari, H. Salvi, and A. Cigli The relation between plasma endothelin-1 levels and metabolic control, risk factors, treatment modalities, and diabetic microangiopathy in patients with type 2 diabetes mellitus J. Diabetes Complic. 15 2001 150 157
3. K. Kamoi, M. Ishibashi, and T. Yamaji Endothelin-1 and big endothelin-1 in NIDDM patients with and without microangiopathy Diabetes Res. Clin. Pract. 24 1994 125 129
4. S.J. Shin, P.J. Hsiao, M.C. Hsieh, Y.J. Lee, and J.H. Tsai Increased urinary endothelin-1 excretion in newly diagnosed type 2 diabetic patients Kaohsiung J. Med. Sci. 15 1999 589 596
5. W. Bagg, C. Ferri, G. Desideri, G. Gamble, P. Ockelford, and G.D. Braatvedt The influences of obesity and glycemic control on endothelial activation in patients with type 2 diabetes J. Clin. Endo. Metab. 86 2001 5491 5497
6. G.M. Hargrove, J. Dufresne, C. Whiteside, D.A. Muruve, and N.C.W. Wong Diabetes mellitus increases endothelin-1 gene transcription in rat kidney Kidney Int. 58 2000 1534 1545
7. Y. Itoh, S. Imanura, K. Yamamoto, Y. Ono, M. Nagata, T. Kobayashi, T. Kato, M. Tomita, A. Nakai, M. Itoh, and A. Nagasaka Changes in endothelin in streptozotocin-induced diabetic rats: effects of an angiotensin converting enzyme inhibitor, enalapril maleate J. Endocrinol. 175 2002 233 239
8. M. Fukui, T. Nakamura, I. Ebihara, S. Osada, Y. Tomino, T. Masaki, K. Goto, Y. Furuichi, and H. Koide Gene expression for endothelins and their receptors in glomeruli of diabetic rats J. Lab. Clin. Med. 122 1993 149 156
9. M.L. Gross, E. Ritz, A. Schoof, M. Adamczak, A. Koch, O. Tulp, A. Parkman, A. El-Shakmak, A. Szabo, and K. Amann Comparison of renal morphology in the streptozotocin and the SHR/N-cp models of diabetes Lab. Invest. 84 2004 452 464
10. R. Mishra, S.N. Emancipator, C. Miller, T. Kern, and M.S. Simonson Adipose differentiation related protein and regulators of lipid homeostasis identified by gene expression profiling in murine db/db diabetic kidney Am. J. Phsyiol. 286 2004 F913 F921
11. A. Benigni, V. Colosio, C. Brena, I. Bruzzi, T. Bertani, and G. Remuzzi Unselective inhibition of endothelin receptors reduces renal dysfunction in experimental diabetes Diabetes 47 1998 450 456
12. S.S. Ding, C. Qiu, P. Hess, J.F. Xi, N. Zheng, and M. Clozel Chronic endothelin receptor blockade prevents both early hyperfiltration and late overt diabetic nephropathy in the rat J. Cardiovasc. Pharmacol. 42 2003 48 54
13. A. Cosenzi, E. Bernobich, R. Trevisan, N. Milutinovic, A. Borri, and G. Bellini Nephroprotective effect of bosentan in diabetic rats J. Cardiovasc. Pharmacol. 42 2003 752 756
14. M.L. Gross, E. Ritz, A. Schoof, B. Helmke, A. Parkman, O. Tulp, K. Munter, and K. Amann Renal damage in the SHR/N-cp type-2 diabetes model: comparison of an angiotensin-converting enzyme inhibitor and endothelin receptor blocker Lab. Invest. 83 2003 1267 1277
15. B. Hocher, A. Schwarz, D. Reinbacher, J. Jacobi, A. Lun, F. Priem, C. Bauer, H.H. Neumayer, and M. Raschack Effects of endothelin receptor antagonists on the progression of diabetic nephropathy Nephron 87 2001 161 169
16. S. Dhein, S. Hockreuther, C. Spring, K. Bolling, C. Hufnagel, and M. Raschack Long-term effect of the endothleinA receptor antagonist LU 135252 and the angiotensin converting enzyme inhibitor trandolapril on diabetic angiopathy and nephropathy in a chronic type 1 diabetes mellitus rat model J. Pharmacol. Exp. Ther. 293 2000 351 359
17. K. Sugimoto, S. Tsuruoka, and A. Fujimura Renal protective effect of YM598, a selective endothelin ET(A) receptor antagonist, against diabetic nephropathy in OLETF rats Eur. J. Pharmacol. 450 2002 183 189
18. S. Chen, T. Evans, D. Deng, M. Cukiernik, and S. Chakrabarti Hyperhexosemia induced functional and structural changes in the kidneys: role of endothelins Nephron 90 2002 86 94
19. D.J. Kelly, S.L. Skinner, R.E. Gilbert, A.J. Cox, M.E. Cooper, and J.L. Wilkinson-Berka Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat Kidney Int. 57 2000 1882 1894
20. A.A. Like, R.L. Lavine, P.L. Poffenbarger, and W.L. Chick Studies in the diabetic mouse: VI. Evolution of glomerular lesions and associate proteinuria Am. J. Pathol. 66 1972 193 224
21. K. Sharma, P. McCue, and S.R. Dunn Diabetic kidney disease in the db/db mouse Am. J. Physiol. 284 2003 F1138 F1144
22. M. Dalla Vestra, A. Saller, E. Bortoloso, M. Mauer, and P. Fioretto Structural involvement in type I and type II diabetic nephropathy Diabetes Metab. 26 2000 8 14
23. M.P. Cohen, K. Sharma, Y. Jin, E. Hud, V.Y. Wu, J. Tomaszewski, and F.N. Ziyadeh Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists: a novel treatment strategy J. Clin. Invest. 95 1995 2338 2345
24. S.W. Hong, M. Isono, S. Chen, M. Iglesias-de la Cruz, D.C. Han, and F.N. Ziyadeh Increased glomerular and tubular expression of transforming growth factor β 1, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse Am. J. Pathol. 158 2001 1653 1663
25. G. Bower, D.M. Brown, M.W. Steffes, R.L. Vernier, and M. Mauer Studies of the glomerular mesangium and the juxtaglomerular apparatus in the genetically diabetic mouse Lab. Invest. 43 1980 333 341
26. F.N. Ziyadeh, B.B. Hoffman, D.C. Han, M.C. Iglesias, S.W. Hong, M. Isono, S. Chen, T.A. McGowen, and K. Sharma Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal anti-transforming growth factor beta antibody in db/db diabetic mice Proc. Natl. Acad. Sci. USA 97 2000 7667 7669
27. G. Wolf Molecular mechanisms of diabetic mesangial cell hypertrophy: A proliferation of novel factors J. Am. Soc. Nephrol. 13 2002 2611 2613
28. D.E. Kohan, and E. Padilla Endothelin-1 is an autocrine factor in rat inner medullary collecting ducts Am. J. Physiol. 263 1992 F607 F612
29. R.L. Miller, and D.E. Kohan Hypoxia regulates endothelin-1 production by the inner medullary collecting duct J. Lab. Clin. Med. 131 1998 45 48
30. C. Zoja, M. Morigi, M. Figliuzzi, I. Bruzzi, S. Oldroyd, A. Benigni, P. Ronco, and G. Remuzzi Proximal tubular cell synthesis and secretion of endothelin-1 on challenge with albumin and other proteins Am. J. Kid. Dis. 26 1995 934 941
31. C. Zoja, A. Benigni, and G. Remuzzi Protein overload activates proximal tubular cells to release vasoactive and inflammatory mediators Exp. Nephrol. 7 1999 420 428
32. S. Suga, N. Yasui, F. Yoshihara, T. Horio, Y. Kawano, K. Kangawa, and R.J. Johnson Endothelin a receptor blockade and endothelin B receptor blockade improve hypokalemic nephropathy by different mechanisms J. Am. Soc. Nephrol. 14 2003 397 406
33. B. Hocher, C. Thone-Reineke, P. Rohmeiss, F. Schmager, T. Slowinski, V. Burst, F. Siegmund, T. Quertermous, C. Bauer, H. Neumayer, W.D. Schleuning, and F. Theuring Endothelin-1 transgenic mice develop glomerulosclerosis, interstitial fibrosis, and renal cysts but not hypertension J. Clin. Invest. 99 1997 1380 1389
34. T. Shindo, H. Kurihara, K. Maemura, Y. Kurihara, O. Ueda, H. Suzuki, T. Kuwaki, K.-H. Ju, Y. Wang, A. Ebihara, H. Nishimatsu, N. Moriyama, M. Fukuda, Y. Akimoto, H. Hirano, H. Morita, M. Kumada, Y. Yazaki, R. Nagai, and K. Kimura Renal damage and salt-dependent hypertension in aged transgenic mice overexpressing endothelin-1 J. Mol. Med. 80 2002 105 116
35. A. Sorokin, and D.E. Kohan Physiology and pathophysiology of endothelin-1 in renal mesangium Am. J. Physiol. 285 2003 F579 F589
36. C. Chatziantoniou, J.J. Boffa, R. Ardailou, and J.C. Dussaule Nitric oxide inhibition induces early activation of type I collagen gene in renal resistance vessels and glomeruli in transgenic mice: role of endothelin J. Clin. Invest. 101 1998 2780 2789
37. M.S. Simonson Endothelins: multifunctional renal peptides Physiol. Rev. 73 1993 375 411
38. J. Ortmann, K. Amann, R.P. Brandes, M. Kretzler, K. Munter, N. Parekh, T. Traupe, M. Lange, T. Lattmann, and M. Barton Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition Hypertension 44 2004 974 981
39. J.J. Boffa, P. Tharaux, J.C. Dussaule, and C. Chatziantoniou Regression of renal vascular fibrosis by endothelin receptor antagonism Hypertension 37 2001 490 496
40. I. Lehrke, R. Waldherr, E. Ritz, and J. Wagner Renal endothelin-1 and endothelin receptor type B expression in glomerular diseases with proteinuria J. Am. Soc. Nephrol. 12 2001 2321 2329
41. D. Gomez-Garre, R. Largo, N. Tejera, J. Fortes, F. Manzarbeitia, and J. Egido Activation of NF-kappaB in tubular epithelial cells of rats with intense proteinuria: role of angiotensin II and endothelin-1 Hypertension 37 2001 1171 1178
42. A.C.M. Ong, T.P. Jowett, J.D. Firth, S. Burton, F.E. Karet, and L.G. Fine An endothelin-1 mediated autocrine growth loop involved in human renal tubular regeneration Kidney Int. 48 1995 390 401